Avantor, Inc. (AVTR)
14.97
-0.22
(-1.45%)
USD |
NYSE |
Sep 04, 16:00
14.96
0.00 (0.00%)
Pre-Market: 20:00
Avantor Cash and Short Term Investments (Annual) : 365.40M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 365.40M |
| December 31, 2024 | 261.90M |
| December 31, 2023 | 262.90M |
| December 31, 2022 | 372.90M |
| December 31, 2021 | 301.70M |
| Date | Value |
|---|---|
| December 31, 2020 | 286.60M |
| December 31, 2019 | 186.70M |
| December 31, 2018 | 184.70M |
| December 31, 2017 | 185.40M |
| December 31, 2016 | 62.90M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Medpace Holdings, Inc. | 497.05M |
| Champions Oncology, Inc. | 4.872M |
| Personalis, Inc. | 239.95M |
| Adaptive Biotechnologies Corp. | 226.98M |
| 10X Genomics, Inc. | 523.41M |